Evaluating only Petriage’s profile at its peak — without knowing the outcome — the model ranked Competition as the #1 likely cause. Documented cause: No market fit.
Key Events Timeline
FOUNDING
Dr. Mathieu Glassman founds Petriage to build AI pet symptom triage for clinics and consumers.
FUNDING
Raises approximately $3M in seed funding from angel investors and early-stage VCs.
PRODUCT LAUNCH
Clinic SaaS version launched; veterinary adoption remains below 2% of target accounts due to liability concerns.
SHUTDOWN
Company quietly ceases operations; no public announcement; annual revenue never exceeded $500K.
Full Analysis
Free · no account needed
Documented cause
Petriage built an AI-powered symptom checker for pets, targeting both consumers and veterinary clinics as a SaaS triage tool. Founded by Dr. Mathieu Glassman in 2016, the company raised approximately $3M in seed funding. The dual B2B/B2C model created focus problems: clinics were slow to adopt a third-party triage tool fearing liability, while consumers used the free tier without converting. Revenue never exceeded $500K annually. By 2021 the company quietly ceased operations without public announcement.
Lesson
“Dual B2B/B2C healthcare SaaS splits focus fatally; choose one customer segment and dominate it.”